News | January 28, 2015

Total cancer deaths expected to drop except for lung cancer in women and pancreatic cancer in both sexes

cancer, lung, breast, EU, European Union, death rates, 2015

January 28, 2015 — Death rates from lung cancer will exceed those for breast cancer for the first time among European women in 2015, according to the latest predictions published in the cancer journal Annals of Oncology.

The study by researchers in Italy and Switzerland predicts that although the actual number of deaths from all cancers in the European Union (EU) will continue to rise due to growing populations and numbers of elderly people, the rate of cancer deaths will continue to decline overall, with some notable exceptions: lung cancer in women and pancreatic cancer in both sexes.

In women, the predicted age-standardized rate of deaths from lung cancer will increase by 9 percent from 2009 to 14.24 per 100,000 of the population, while the death rates from breast cancer are predicted to be 14.22 per 100,000, which represents a fall of 10.2 percent since 2009. However, the total number of deaths will remain slightly higher for breast cancer (90,800) than for lung (87,500).

Carlo La Vecchia, M.D., professor at the Faculty of Medicine, University of Milan (Italy), one of the study authors, said: "We still have to be cautious about the lung cancer rates in women since these are predictions. The data for real death rates in 2015 in the EU as a whole will be available in three to four years. Further caution is required due to the fact that the absolute numbers of deaths in 2015 remains higher for breast than for lung. However, the 2015 predictions confirm our projections on long-term trends made two years ago that lung cancer death rates would overtake breast cancer in women around 2015."

The overall death rate for lung cancer among women is being driven by women in the U.K. and Poland, with predicted rates of 21 and 17 per 100,000 in the U.K. and Poland, respectively. These rates are more than double those in Spain, which has a lung cancer death rate among women of just over eight per 100,000.

"U.K. and Polish women, particularly U.K. women, have long had much higher lung cancer rates than most other European countries (except Denmark, which is not considered separately in this study). This is due to the fact that British women started smoking during the Second World War, while in most other EU countries women started to smoke after 1968. It is worrying that female lung cancer rates are not decreasing in the U.K., but this probably reflects the fact that there was an additional rise in smoking prevalence in the U.K. as well in the post-1968 generation - those born after 1950," said La Vecchia. "However, despite the relatively lower rates of women dying from lung cancer in other EU countries, the trends are less favourable in some countries, particularly in France and Spain."

The study predicts that there will be a total of 1,359,100 deaths from cancer in the 28 member states of the EU in 2015 (766,200 men and 592,900 women), corresponding to an age-standardized rate of 138.4 per 100,0000 men and 83.9 per 100,000 women. This represents a fall of 7.5 percent and 6 percent in men and women respectively since 2009, and an overall fall of 26 percent in men and 21 percent in women since the peak of cancer death rates in 1988. More than 325,000 deaths will be avoided in 2015 compared with the 1988 peak rate.

The study looked at cancer rates in the 28 EU member states as a whole and also in the six largest countries — France, Germany, Italy, Poland, Spain and the UK — for all cancers, and, individually, for stomach, intestines, pancreas, lung, prostate, breast, uterus (including cervix) and leukaemias. This is the fifth consecutive year the researchers have published these predictions.

For more information:  www.annonc.oxfordjournals.org/content/early/recent


Related Content

News | Breast Biopsy Systems

Feb. 18, 2026 — Mammotome, a Danaher company, has introduced the Mammotome Prima MR Dual Vacuum-Assisted Breast Biopsy ...

Time February 18, 2026
arrow
News | Breast Imaging

Feb. 16, 2026 — Rising demand for breast cancer screening and diagnostics is outpacing the supply of available breast ...

Time February 17, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Feb. 5, 2026 — Eyas Medical Imaging, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its ...

Time February 06, 2026
arrow
News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Radiation Therapy

Feb. 4, 2026 — On World Cancer Day (02.04.26), the American Society for Radiation Oncology (ASTRO) and the European ...

Time February 04, 2026
arrow
News | Radiology Imaging

Feb. 4, 2026 — The Royal College of Radiologists (RCR) has issued its initial reaction to the British government's ...

Time February 04, 2026
arrow
News | FDA

Feb. 2, 2026 — Imagion Biosystems, Ltd. has submitted an Investigational New Drug (IND) application with the U.S. Food ...

Time February 02, 2026
arrow
News | Breast Imaging | Washington University

Jan. 22, 2026 — In breast cancer, a biopsy is the only diagnostic procedure that can determine if a suspicious lump or ...

Time January 29, 2026
arrow
News | Radiation Oncology

Jan. 27, 2026 — Researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with other leading ...

Time January 29, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
Subscribe Now